Internal Medicine, Medical Oncology · Saint Louis, MO
NPI
1790988053
Since 2007
Specialty
Internal Medicine, Medical Oncology
Code 207RX0202X
Group practices
2
Medicare group memberships
Hospitals
5
Hospital affiliations
4921 Parkview Pl, Div Im Medical Oncology, Ste 7a, 7b, 7c
Saint Louis, MO, 63110
Phone (800) 647-2098
Groups this clinician bills Medicare through
Medicare paid, 2024
$817K
31,714 services
Medicare patients, 2024
294
Average age 73
Drug cost, 2024
$1.5M
707 prescriptions
Company payments, 2025
$19K
From 8 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by George Ansstas was code J1100 (injection, dexamethasone sodium phosphate, 1 mg), 360 times for 20 patients. In total George Ansstas billed 31,714 services in 95 codes, and Medicare paid $817K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-04-15.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 360 | 20 | $0.08 | $30.47 |
| 99214 Office E&M - Established | Office | 338 | 133 | $95.06 | $32K |
| J1626 Injection, granisetron hydrochloride, 100 mcg | Office | 210 | 11 | $0.24 | $50.73 |
| J2469 Injection, palonosetron hcl, 25 mcg | Office | 190 | 11 | $0.79 | $150 |
| 36415 Venipuncture Blood Collection | Office | 119 | 52 | $8.65 | $1,029 |
| 96413 Chemotherapy Administration | Office | 88 | 52 | $85.74 | $7,545 |
| 96375 Injection Administration | Office | 71 | 27 | $10.89 | $773 |
| 96367 Intravenous Infusion, Hydration | Office | 37 | 21 | $20.70 | $766 |
| 96372 Injection Administration | Office | 32 | 24 | $9.19 | $294 |
| J7030 Infusion, normal saline solution , 1000 cc | Office | 25 | 20 | $1.95 | $48.76 |
| 99222 Hospital E&M - Initial | Facility | 20 | 20 | $104.11 | $2,082 |
| 99232 Hospital E&M - Subsequent | Facility | 18 | 14 | $59.12 | $1,064 |
| 96417 Chemotherapy Administration | Office | 17 | 13 | $42.24 | $718 |
| 99205 Office E&M - New | Office | 16 | 16 | $153.84 | $2,461 |
| 96365 Intravenous Infusion, Hydration | Office | 16 | 14 | $41.53 | $664 |
By year: 2022 $1.7M for 83,914 services; 2023 $1.2M for 57,581 services; 2024 $817K for 31,714 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 119 | 52 | $8.65 | $1,029 |
Medicare prescription drug claims, 2024
In 2024, the drug George Ansstas prescribed most often to Medicare patients was Prednisone, with 92 prescriptions and refills. In total George Ansstas wrote 707 Medicare prescriptions that cost $1.5M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Prednisone Generic | 92 | 121 | 23 | $502 |
| Levothyroxine Sodium Generic | 81 | 173 | 19 | $344 |
| Prochlorperazine Maleate Generic | 53 | 53 | 31 | $1,245 |
| Mektovi Binimetinib | 47 | 47 | Under 11 | $694K |
| Braftovi Encorafenib | 39 | 39 | Under 11 | $631K |
| Eliquis Apixaban | 30 | 36 | Under 11 | $22K |
| Hydrocortisone Generic | 30 | 32 | Under 11 | $417 |
| Gabapentin Generic | 28 | 40 | Under 11 | $400 |
| Triamcinolone Acetonide Generic | 21 | 32 | 15 | $248 |
| Hydroxyzine Hcl Generic | 17 | 19 | Under 11 | $191 |
| Celecoxib Generic | 17 | 25 | Under 11 | $179 |
| Oxycodone Hcl Generic | 16 | 16 | Under 11 | $255 |
| Dexamethasone Generic | 15 | 15 | Under 11 | $159 |
| Methylphenidate Hcl Generic | 15 | 15 | Under 11 | $118 |
| Pantoprazole Sodium Generic | 14 | 16 | Under 11 | $26.92 |
Brand drugs: 194 claims; generic drugs: 513 claims; opioid claims: 23.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid George Ansstas $19K ($19K in general payments such as food, travel and fees) from 8 companies. The largest payer was Regeneron Pharmaceuticals, Inc. with $10K.
| Company | Payments | Amount |
|---|---|---|
| Regeneron Pharmaceuticals, Inc. REGN | 13 | $10K |
| Sun Pharmaceutical Industries Inc. SUNPHARMA.NS | 10 | $8,866 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.